ReviewPharmacological reviews2025
Neuropeptides as transmitters and regulators of the locus coeruleus noradrenergic system.
Review in Pharmacological reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Molecular programs in human locus coeruleus link APOE and neuromelanin to Alzheimer's vulnerability.Acta neuropathologica · 2026Article
- Altered locus coeruleus functional connectivity in migraine without aura based on resting-state functional magnetic resonance imaging.Journal of oral & facial pain and headache · 2026Article
- Impact of Alzheimer's disease risk factors and local neuromelanin content on the transcriptomic landscape of the human locus coeruleus.bioRxiv : the preprint server for biology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
The locus coeruleus (LC), the brain's main source of noradrenaline, has received increased attention due to the recently unveiled heterogeneity of its cell types. Departing from the long-standing idea of molecular, anatomical, and functional uniformity of the structure, we now understand the LC as a multiplexed nucleus, capable of temporally precise and targeted neuromodulation of distinct brain regions and functions. The LC neuropeptidergic landscape provides a window into this remarkable neuronal diversity. Stemming from recent technological advances that have allowed for LC transcriptional profiling, a wealth of data on the (co)expression of LC neuropeptides and their cognate receptors has come to light. Peptidergic systems are ideally situated to exert neuromodulatory control over the LC noradrenergic system. This peptidergic control can occur both locally, within the LC and the neighboring peri-LC microcircuitry, and at distal LC terminal fields. The functional significance of LC neuropeptidergic signaling in physiological processes and pathological conditions is an emerging field. Here we compile existing literature on the expression, anatomical distribution, physiological effects, and, when available, behavioral role of the major neuropeptidergic populations of, and innervating, the LC and peri-LC. Furthermore, we highlight current methodologies that delineate LC peptidergic input/output, aiming at uncovering their functional role. Finally, we discuss how neuropeptidergic signaling enables LC modularity and thus sustains a multifaceted role of physiological noradrenaline release dynamics with a rich feature set of behavioral representations. SIGNIFICANCE STATEMENT: The locus coeruleus (LC) noradrenergic system influences a variety of neurophysiological processes to coordinate complex behaviors. These far-reaching neuromodulatory effects are not solely mediated by noradrenaline, but rather, by a variety of coreleased neuropeptides that can alter postsynaptic responses in LC terminal regions. In addition, the LC itself is regulated by a multitude of incoming peptidergic signals that drive wide-ranging changes in LC neuronal physiology and the subsequent patterns of noradrenaline release. It is important to understand how neuropeptide (co)transmitters and regulators of the LC can drive circuit-level plasticity and adaptive behavioral responses to changing environmental stimuli. This review compiles our current understanding of these processes, providing additionally crucial insights into the mechanisms underlying LC dysfunction and its many related neuropsychiatric conditions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.